| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851937 | American Heart Journal | 2006 | 6 Pages |
Abstract
High-dose candesartan cilexetil therapy in patients with symptomatic coronary artery disease undergoing coronary stent implantation does not reduce clinical event rates, restenosis rates, or neointimal proliferation after elective stent implantation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter W. MD, Hans R. MD, Helmut MD, Heinrich G. MD, Andreas MD, Sigmund MD, Werner MD, Alexander MD, Nicolaus MD, Wolfgang MD, Hans-Joachim MD, Dieter MD, Jan R. MD, Kerstin MD, Rainer MD, Peter MD,